Literature DB >> 15717192

[Results of the Collaborative Initial Glaucoma Treatment Study (CIGTS)].

J Wahl1.   

Abstract

The Collaborative Initial Glaucoma Treatment Study (CIGTS) was initiated to evaluate whether local medical therapy or trabeculectomy is the better initial treatment for patients with newly diagnosed open-angle glaucoma. Visual field progression, intraocular pressure, and visual acuity were to be monitored for a period of 5 years. A total of 607 patients were randomly distributed among the two groups and controlled at 6-month intervals. At the same time the investigators tried to record quality of life using a questionnaire. Both trabeculectomy and medical therapy were able to lower intraocular pressure significantly, whereas trabeculectomy was more effective. The results of the questionnaire showed only minor differences between the two groups. The medically treated patients reported slightly more ocular symptoms than the patients in the trabeculectomy group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717192     DOI: 10.1007/s00347-005-1173-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.

Authors:  D C Musch; P R Lichter; K E Guire; C L Standardi
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

3.  Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.

Authors:  N K Janz; P A Wren; P R Lichter; D C Musch; B W Gillespie; K E Guire
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

4.  Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group.

Authors:  J W Kim; W R Freeman; S P Azen; W el-Haig; D J Klein; I L Bailey
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

5.  The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma.

Authors:  N K Janz; P A Wren; P R Lichter; D C Musch; B W Gillespie; K E Guire; R P Mills
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

6.  Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.

Authors:  J Katz; N Congdon; D S Friedman
Journal:  Arch Ophthalmol       Date:  1999-09

7.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

8.  Collaborative Initial Glaucoma Treatment Study: a summary of results to date.

Authors:  Leonard Feiner; Jody R Piltz-Seymour
Journal:  Curr Opin Ophthalmol       Date:  2003-04       Impact factor: 3.761

9.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

10.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  2 in total

1.  [Position statement of the German Ophthalmological Society on early recognition of glaucoma : August 2015].

Authors: 
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

2.  Glaucoma prescribing trends in England 2000 to 2012.

Authors:  A J Connor; S G Fraser
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.